Reiffel JA - Search Results

1

Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.

Durheim MT, Holmes DN, Blanco RG, Allen LA, Chan PS, Freeman JV, Fonarow GC, Go AS, Hylek EM, Mahaffey KW, Pokorney SD, Reiffel JA, Singer DE, Peterson ED, Piccini JP. Durheim MT, et al. Among authors: reiffel ja. Heart. 2018 Nov;104(22):1850-1858. doi: 10.1136/heartjnl-2017-312735. Epub 2018 Jun 6. Heart. 2018. PMID: 29875139

2

Impact of structural heart disease on the selection of class III antiarrhythmics for the prevention of atrial fibrillation and flutter.

Reiffel JA. Reiffel JA. Am Heart J. 1998 Apr;135(4):551-6. doi: 10.1016/s0002-8703(98)70266-2. Am Heart J. 1998. PMID: 9539466 Review.

3

Rhythm management in atrial fibrillation--with a primary emphasis on pharmacological therapy: Part 1.

Blitzer M, Costeas C, Kassotis J, Reiffel JA. Blitzer M, et al. Among authors: reiffel ja. Pacing Clin Electrophysiol. 1998 Mar;21(3):590-602. doi: 10.1111/j.1540-8159.1998.tb00103.x. Pacing Clin Electrophysiol. 1998. PMID: 9558692 Review.

4

Rhythm management in atrial fibrillation--with a primary emphasis on pharmacological therapy: Part 2.

Costeas C, Kassotis J, Blitzer M, Reiffel JA. Costeas C, et al. Among authors: reiffel ja. Pacing Clin Electrophysiol. 1998 Apr;21(4 Pt 1):742-52. doi: 10.1111/j.1540-8159.1998.tb00132.x. Pacing Clin Electrophysiol. 1998. PMID: 9584306 Review.

5

Rhythm management in atrial fibrillation--with a primary emphasis on pharmacologic therapy: Part 3.

Kassotis J, Costeas C, Blitzer M, Reiffel JA. Kassotis J, et al. Among authors: reiffel ja. Pacing Clin Electrophysiol. 1998 May;21(5):1133-45. doi: 10.1111/j.1540-8159.1998.tb00160.x. Pacing Clin Electrophysiol. 1998. PMID: 9604246 Review.

6

Selecting an antiarrhythmic agent for atrial fibrillation should be a patient-specific, data-driven decision.

Reiffel JA. Reiffel JA. Am J Cardiol. 1998 Oct 16;82(8A):72N-81N. doi: 10.1016/s0002-9149(98)00588-8. Am J Cardiol. 1998. PMID: 9809904 Free article. Review.

7

Drug choices in the treatment of atrial fibrillation.

Reiffel JA. Reiffel JA. Am J Cardiol. 2000 May 25;85(10A):12D-19D. doi: 10.1016/s0002-9149(00)00902-4. Am J Cardiol. 2000. PMID: 10822036 Review.

8

New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?

Morrow JP, Cannon CP, Reiffel JA. Morrow JP, et al. Among authors: reiffel ja. Am Heart J. 2007 Nov;154(5):824-9. doi: 10.1016/j.ahj.2007.06.041. Am Heart J. 2007. PMID: 17967585 Review.

9

A contemporary look at classic trials in atrial fibrillation: what do they really show and how might they apply to future therapies?

Reiffel JA. Reiffel JA. Am J Cardiol. 2008 Sep 22;102(6A):3H-11H. doi: 10.1016/j.amjcard.2008.06.024. Am J Cardiol. 2008. PMID: 18790109 Review.

10

Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank.

Al-Khatib SM, Calkins H, Eloff BC, Packer DL, Ellenbogen KA, Hammill SC, Natale A, Page RL, Prystowsky E, Jackman WM, Stevenson WG, Waldo AL, Wilber D, Kowey P, Yaross MS, Mark DB, Reiffel J, Finkle JK, Marinac-Dabic D, Pinnow E, Sager P, Sedrakyan A, Canos D, Gross T, Berliner E, Krucoff MW. Al-Khatib SM, et al. Am Heart J. 2010 Jan;159(1):17-24. doi: 10.1016/j.ahj.2009.10.018. Am Heart J. 2010. PMID: 20102862 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

287 results

Search Page